The potential use of lactate blockers for the prevention of COVID-19 worst outcome, insights from exercise immunology

Autor: Rokaya El-Sayed, Emmy Abdelfatah, Merna Luis, Mariem Arsanyous, Rania Abdelaziz, Mariam Abdelaziz, Rafeef Hozaien, Maram Rajab, Verina Fouad, Nada Gamal, Reem J. Husseiny, Passant Elshawarbi, Amr Elkhateb, Elaria Yacoub, Joseph Shehata, Reem Yasser, Mark Michael, Rawan Elsayed, Areeg ElShaarawy, Antoine Fakhry AbdelMassih, Ramy Gayed, Taquwa Aly, Shenoda Yacoub, Mahmoud Seyam, Rahma Menshawey, Lauren Nathan, Marihan Ghazy, Rana AbdelHaleem, Nada AlShehry, Yousef Husseiny, Hutaf Jaber, Sherry Rateb, Estfana Eskandar, Omnia Mohamed, Shahd Ragab, Basant Eltaher, Mariam Messiha, Febronia Nasry, Mayada Elfishawy, Nadine El-Husseiny, Nada Ali, Kirollos Badr, Marian Eesa, Omar Medhat, Noha M. Khalil, Alaa Amr, Ahmed El-Maghraby, Mai Mustafa, Amin Mabrouk, Mostafa AmanAllah, Yara Mahjoub, Omnya Mahmoud Aly, Esraa Menshawey, Hesham Sheashaa, Nadine Elgamal, Nourhan Hassan, Ahmed Sabry, Doaa Massoud, Assem Kassim, Aia Mohamed Hanoura, Fady Mishriky, Peter Kelada, Alaa Saud, Sara Tayssir, Noha Abdelmoneim, Youssef Nada, Rahma Hassan Galal, Aya Kamel
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
ALI
acute lung injury

M2
wound-healing macrophages

Lactate blockers
0302 clinical medicine
DC
dendritic cells

M1
inflammatory macrophages

Anaerobiosis
NK cell
natural killer cell

Th cells
T helper cells

cDCs
conventional dendritic cells

VO2 max
General Medicine
Acquired immune system
LPS
lipopolysacchride

PA
physical activity

Endurance training
HIV
human immunodeficiency virus

VO2 Max
maximum volume of oxygen

CRP
C-reactive protein

medicine.symptom
Anaerobic exercise
IT
immunotype

NETs
neutrophil extracellular traps

FSC
forward scatter

PPARγ
peroxisome proliferator-activated receptor gamma

COVID-19
coronavirus 19

CD
cluster of differentiation

pDCs
plasmocytoid dendritic cells

Inflammation
Physical exercise
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2

Article
03 medical and health sciences
B cell
bursa-derived lymphocyte

Tcell
thymus-derived lymphocyte

medicine
Humans
Lactic Acid
Exercise physiology
Exercise
Pandemics
AM
alveolar macrophages

ARDS
acute respiratory distress syndrome

Sweat lactate
business.industry
Interleukin-6
SARS-CoV-2
Models
Immunological

COVID-19
Hypoxia (medical)
IL
interleukin

COVID-19 Drug Treatment
030104 developmental biology
FCN-1
ficolin-1

ES
endostatin

FABP4
fatty acid binding protein 4

Immunology
OPN
osteopontin

Anti HSA antibody
anti-human serum albumin antibody

business
SPP1+
secreted phosphoprotein 1

030217 neurology & neurosurgery
Zdroj: Medical Hypotheses
ISSN: 0306-9877
DOI: 10.1016/j.mehy.2021.110520
Popis: Following the decline in Physical Activity (PA) due to COVID-19 restrictions in the form of government mandated lockdowns and closures of public spaces, the modulatory effect of physical exercise on immunity is being heavily revisited. In an attempt to comprehend the wide discrepancy in patient response to COVID-19 and the factors that potentially modulate it, we summarize the findings relating PA to inflammation and immunity. A distinction is drawn between moderate intensity and high intensity physical exercise based on the high lactate production observed in the latter. We hypothesize that, the lactate production associated with high intensity anaerobic exercise is implicated in the modulation of several components of the innate and adaptive immunity. In this review, we also summarize these immunomodulatory effects of lactate. These include increasing serum IL-6 levels, the main mediator of cytokine storms, as well as affecting NK cells, Macrophages, Dendritic cells and cytotoxic T-lymphocytes. The implications of high lactate levels in athletic performance are highlighted where athletes should undergo endurance training to increase VO2 max and minimize lactate production. Tumor models of hypoxia were also reported where lactate levels are elevated leading to increased invasiveness and angiogenesis. Accordingly, the novel lactate blocking strategy employed in cancer treatment is evaluated for its potential benefit in COVID-19 in addition to the readily available beta-blockers as an antagonist to lactate. Finally, we suggest the diagnostic/prognostic purpose of the elevated lactate levels that can be determined through sweat lactate testing. It is the detrimental effect of lactate on immunity and its presence in sweat that qualify it to be used as a potential non-invasive marker of poor COVID-19 outcome.
Databáze: OpenAIRE